JKI 22 Pill - beige oval, 11mm

Generic Name: tofacitinib

Pill with imprint JKI 22 is Beige, Oval and has been identified as Xeljanz XR 22 mg. It is supplied by Pfizer Inc.

Xeljanz XR is used in the treatment of Ankylosing Spondylitis; Ulcerative Colitis; Psoriatic Arthritis; Rheumatoid Arthritis and belongs to the drug class antirheumatics. Risk cannot be ruled out during pregnancy. Xeljanz XR 22 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for JKI 22

Xeljanz XR

Generic Name

tofacitinib

Imprint

JKI 22

Strength

22 mg

Color

Beige

Size

11.00 mm

Shape

Oval

Availability

Prescription only

Drug Class

Antirheumatics

Pregnancy Category

C - Risk cannot be ruled out

CSA Schedule

Not a controlled drug

Labeler / Supplier

Pfizer Inc.

National Drug Code (NDC)

00069-0502

Print

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer